Your browser doesn't support javascript.
loading
Autoimmunity in narcolepsy.
Bonvalet, Melodie; Ollila, Hanna M; Ambati, Aditya; Mignot, Emmanuel.
Afiliação
  • Bonvalet M; aDepartment of Psychiatry and Behavioral Sciences, Center for Sleep Sciences, Stanford University School of Medicine, Palo Alto, California, USA bNational Institute for Health and Welfare, Public Genomics Unit cInstitute for Molecular Medicine FIMM, University of Helsinki, Helsinki, Finland.
Curr Opin Pulm Med ; 23(6): 522-529, 2017 11.
Article em En | MEDLINE | ID: mdl-28991006
PURPOSE OF REVIEW: Summarize the recent findings in narcolepsy focusing on the environmental and genetic risk factors in disease development. RECENT FINDINGS: Both genetic and epidemiological evidence point towards an autoimmune mechanism in the destruction of orexin/hypocretin neurons. Recent studies suggest both humoral and cellular immune responses in the disease development. SUMMARY: Narcolepsy is a severe sleep disorder, in which neurons producing orexin/hypocretin in the hypothalamus are destroyed. The core symptoms of narcolepsy are debilitating, extreme sleepiness, cataplexy, and abnormalities in the structure of sleep. Both genetic and epidemiological evidence point towards an autoimmune mechanism in the destruction of orexin/hypocretin neurons. Importantly, the highest environmental risk is seen with influenza-A infection and immunization. However, how the cells are destroyed is currently unknown. In this review we summarize the disease symptoms, and focus on the immunological findings in narcolepsy. We also discuss the environmental and genetic risk factors as well as propose a model for disease development.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoimunidade / Narcolepsia Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoimunidade / Narcolepsia Idioma: En Ano de publicação: 2017 Tipo de documento: Article